Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.
Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
Join us for this live national webinar designed to bridge real-world patient perspectives with the latest advances in metastatic breast cancer (MBC) care.
Join us for a dynamic, live webinar where two leading GI oncology experts will break down the latest advancements in biomarker-based, first-line treatment strategies for upper gastrointestinal (GI) cancers.
Embark on the path to become an expert injector! This program provides you with the knowledge and practical skills needed to succeed. Class size is limited to 8, ensuring you receive an individualized training environment. Models are provided.
Join us for a live, interactive TheraTalk session with an expert panel of nationally recognized lipid specialists as they review the latest guideline recommendations, pivotal evidence, and evolving strategies for LDL-C management.
Enhance your expertise in MASH diagnosis and management with this one-of-a-kind preceptorship. Join us for a two-part training experience that will elevate your skills and connect you with a network of liver-focused professionals. Apply today!
Current evidence-based recommendations for prescribing diabetes medications, including newer pharmacologic classes such as glucagon-like peptide-1 receptor agonists (GLP-1r) and sodium glucose co-transporter-2 inhibitors (SGLTi) medications.
Close the technology gap and improve patient outcomes , this program provides a review of the latest diabetes technologies, including continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, and smart insulin pens.
This dynamic, expert-led live webinar is designed to help you navigate the treatment landscape for advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
